Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 4/20 | 0.40 |
| ▸ | CTSK | P43235 | 4/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | CTSL | P07711 | 2/20 | 0.38 |
| ▸ | CTSV | O60911 | 1/20 | 0.36 |
| ▸ | PLAT | P00750 | 1/20 | 0.36 |
| ▸ | CTSH | P09668 | 1/20 | 0.36 |
| ▸ | CASP14 | P31944 | 1/20 | 0.36 |
| ▸ | CASP6 | P55212 | 1/20 | 0.36 |
| ▸ | CTSZ | Q9UBR2 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6209675 | 0.91 | CTSS (0.31) | CTSSCTSKRAB9A | |
| SCHEMBL4838488 | 0.90 | RAB9A (0.39) | CTSSCTSKRAB9ACTSLCTSV | |
| SCHEMBL5553533 | 0.90 | RAB9A (0.39) | CTSSCTSKRAB9ACTSLCTSV | |
| SCHEMBL5550471 | 0.88 | CTSS (0.42) | CTSSCTSKRAB9ACTSL | |
| SCHEMBL5549818 | 0.88 | CTSS (0.39) | CTSSCTSKRAB9ACTSLCTSV | |
| SCHEMBL5553462 | 0.87 | IDH2 (0.41) | CTSSCTSKRAB9ACTSL | |
| SCHEMBL5553518 | 0.87 | RAB9A (0.37) | CTSSCTSKRAB9ACTSL | |
| SCHEMBL5553411 | 0.86 | CTSS (0.38) | CTSSCTSKRAB9ACTSLCTSV | |
| SCHEMBL5029060 | 0.83 | RAB9A (0.41) | CTSSCTSKRAB9ACTSLCTSV | |
| SCHEMBL6013841 | 0.81 | GALR1 (0.44) | CTSSCTSKRAB9ACTSL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7268134-B2 | Medical devices employing triazine compounds and compositions thereof | REDDY US THERAPEUTICS, INC. (US) | 2007-09-11 | — | — | US | disclosed |
| US-20050113341-A1 | Medical devices employing triazine compounds and compositions thereof | DR. REDDY'S LABORATORIES LTD. (IN) | 2005-05-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050113341-A1 | Medical devices employing triazine compounds and compositions thereof | PTGIS, AREG, TGFB1 | CTSS 2220/4885CTSK 2933/4885RAB9A 4800/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.